Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in
For Indian pharmaceutical exports, the US represents the primary market, comprising approximately 35% of total exports, with a value reaching about $10 billion in FY25. (AI image) US President Donald Trump’s move to impose 100% tariffs on branded and patented pharmaceutical exports has rattled Indian pharma stocks, even though most companies earn from US markets…
